Isofol Medical AB   Report issue

For profit Phase 2 Phase 3
Founded: Gothenburg Sweden (2008)

Organization Overview

First Clinical Trial
2011
NCT01397305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Isofol Medical AB

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Osteosarcoma (Phase 2)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 9